In addition, its non-significant impact on OS under both chemotherapy alone and HSCT and non-independent prognostic role in both B-other and Ph-negative BCP-ALL reflected that the prognostic significance of ZNF384 fusion was not strong enough. This evidence concerns the gene ZNF384 and acute lymphoblastic leukemia.